Search results
AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
Clinical Trials Arena via Yahoo Finance· 2 hours agoWhile AstraZeneca originally hoped for approval for all HR...III KEYNOTE-522 trial (NCT03036488) of...
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters via AOL· 1 day agoTriple-negative breast cancer remains one of the most challenging forms of disease to treat due to...
CNN Host Sara Sidner Returns After 2 Mastectomies, Radiation, 15 Rounds of Chemo
The Daily Beast via Yahoo News· 6 days agoSidner told People magazine she underwent a mammogram after finding a lump on her breast just before...
Reveal Genomics launches HER2+ breast cancer diagnostics trial
Medical Device Network via Yahoo Finance· 22 hours agoSpanish biotech start-up, Reveal Genomics, has announced the launch of a trial evaluating the...
UPMC moving forward with clinical trials for early stage breast cancer vaccine
Pittsburgh Tribune-Review· 22 hours agoThrough an upcoming clinical trial, approximately 50 women will receive a new vaccine for early-stage breast cancer developed by UPMC ...
AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial -...
Benzinga· 1 day agoThe study did not meet the dual primary endpoints of improvement in overall survival (OS) versus...
Recognizing signs of breast cancer in older women
Medical News Today· 7 days agoMost breast cancers are found in females aged 45 years or older, with the average age of diagnosis being around 62 years. Early signs of breast ...
Surviving to Thriving: Enhancing QoL in Breast Cancer
Medscape· 5 days agoThe growing number of breast cancer survivors highlights the need for holistic and coordinated...
UK cancer care lagging 20 years behind Europe
The Telegraph via Yahoo News· 15 hours agoAn NHS spokesman said: “The NHS is seeing and treating record numbers of people for cancer, with more people diagnosed at an earlier stage than ever...
AstraZeneca's Advanced Breast Cancer Drug Fails to Meet Primary Goals
Morningstar· 1 day agoAstraZeneca said a late-stage study showed that its therapy for advanced or metastatic triple-negative breast cancer didn't meet its ...